FOLH1 and prostate cancer: Previously published studies on the biodistribution and kinetics of 68Ga-PSMA-11 in prostate cancer patients reported increasing SUV in tumor lesions from early to late imaging and rapid blood clearance of 68Ga-PSMA-11 [10–12].